Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 39Leukemia 16Congenital Abnormalities 10Leukemia, Monocytic, Acute 8Leukemia, Myelomonocytic, Acute 7Leukemia, Megakaryoblastic, Acute 6Leukemia, Erythroblastic, Acute 6Myelodysplastic Syndromes 5Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Eosinophilic, Acute 3Anemia, Refractory, with Excess of Blasts 3Leukemia, Promyelocytic, Acute 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Basophilic, Acute 2Neoplasms 1Myeloproliferative Disorders 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1

Interventions

Whole-Body Irradiation 14Mycophenolic Acid 14fludarabine phosphate 13Cyclophosphamide 13Cytarabine 11Methotrexate 9Granulocyte Colony-Stimulating Factor 9Filgrastim 9Cyclosporine 8Peripheral Blood Stem Cell Transplantation 7Vincristine 6Thiotepa 6Tacrolimus 6Dexamethasone 6Cord Blood Stem Cell Transplantation 6merphos 5fludarabine 5Mitoxantrone 5Clofarabine 5Calcium Dobesilate 5Busulfan 5Mercaptopurine 4Melphalan 4Leucovorin 4Cladribine 4pegaspargase 3dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Specimen Handling 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Biphenotypic, Acute × Idarubicin × Clear all
NCT02135874 2024-03-22

Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia

M.D. Anderson Cancer Center

Phase 2 Completed
16 enrolled 9 charts
Other hematologic neoplasm

Leukemia, Biphenotypic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡